Trial
NCT05516875
Open-Label Extension Study of ASTORIA
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Contera Pharma A/S
Collaborators
—
Condition
Dyskinesias
Intervention
JM-010
Why stopped
The trial is terminated based on business decision, not due to safety concerns or regulatory requirements.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-15